L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBNLes informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Frais de port :
EUR 2,42
Vers Etats-Unis
Description du livre Etat : New. N° de réf. du vendeur 2058675-n
Description du livre HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur FT-9789067643948
Description du livre Etat : New. N° de réf. du vendeur 2058675-n
Description du livre Etat : New. N° de réf. du vendeur 6666-TNF-9789067643948
Description du livre Etat : new. N° de réf. du vendeur 7ef329472f10026ec18ac4ad797e703f
Description du livre HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur FT-9789067643948
Description du livre Hardcover. Etat : new. Hardcover. The first unequivocal success for Gene Therapy was reported in April 2000 for X-SCID patients. Pioneering stem cell/gene therapy clinical trials are the focus of this book. Therapy successes such as the X-SCID trial and improved ADA-SCID ones are presented together with pioneering angio/vasculogenic clinical trials mediated either by transient gene therapy or emerging autologous stem cell transplantation. Highlights also include 1) promises of the breakthrough combination of stem cell- and transient gene-therapy, 2) gene therapy trials for neurodegenerative disease on non-human primates where long-term gene therapy might involve brain stem cells, and 3) the first clinical trial with non-invasive monitoring of therapeutic gene expression as a prospective conclusion. This volume will be of value and interest to researchers in this exciting field. The first unequivocal success for Gene Therapy was reported in April 2000 for X-SCID patients. Pioneering stem cell/gene therapy clinical trials are the focus of this book. Therapy successes such as the X-SCID trial and improved ADA-SCID ones are presented together with pioneering angio/vasculogenic clinical trials mediated either by transient gene therapy or emerging autologous stem cell transplantation. Highlights also include 1) promises of the breakthrough combination of stem cell- and transient gene-therapy, 2) gene therapy trials for neurodegenerative disease on non-human primates where long-term gene therapy might involve brain stem cells, and 3) the first clinical trial with non-invasive monitoring of therapeutic gene expression as a prospective conclusion. This volume will be of value and interest to researchers in this exciting field. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9789067643948
Description du livre Hardcover. Etat : Brand New. illustrated edition. 330 pages. 9.50x6.25x0.75 inches. In Stock. N° de réf. du vendeur __9067643947